Immunohistochemistry Market, By Offering (Antibodies, Reagents, Equipment, Kits, and Software), By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
REPORT HIGHLIGHT
Immunohistochemistry Market size was valued at USD 2,876 Million in 2024, expanding at a CAGR of 6.6% from 2024 to 2032.
The Immunohistochemistry (IHC) market encompasses the development, production, and distribution of antibodies, reagents, detection kits, instruments, and associated services used in IHC techniques. Immunohistochemistry is a laboratory method that utilizes antibodies to identify specific antigens in tissue samples, playing a critical role in disease diagnosis—particularly cancer—as well as in biomedical research.
The market serves a broad range of end-users including hospitals, diagnostic laboratories, academic and research institutions, and pharmaceutical companies. Key drivers of growth include the rising global burden of chronic diseases such as cancer and cardiovascular conditions, increasing demand for precise and personalized diagnostic tools, and continuous advancements in IHC automation and imaging technologies. Moreover, growing investment in healthcare infrastructure, expanding applications in drug development, and the global push for early disease detection further support the robust expansion of the IHC market.
Immunohistochemistry Market- Market Dynamics
Rising Prevalence of Chronic Diseases
The increasing incidence of chronic diseases, particularly cancer, is a key driver of the immunohistochemistry (IHC) market. IHC is essential for the accurate diagnosis and classification of cancers by detecting specific biomarkers within tissue samples, enabling personalized treatment strategies and improved patient outcomes. As global cancer rates and other chronic conditions rise—driven by aging populations and lifestyle changes—the demand for precise diagnostic methods like IHC continues to grow. According to the World Health Organization (WHO), cancer is a leading cause of death worldwide, responsible for nearly 10 million deaths in 2020, prompting governments globally to prioritize early diagnosis and advanced diagnostic technologies through increased funding and regulatory support. Furthermore, the expanding application of IHC in research and drug development supports advancements in targeted therapies and precision medicine, further fueling market growth.
Immunohistochemistry Market- Segmentation Analysis:
The global Immunohistochemistry Market is divided into Four categories: Offering, Application, End User, and Region.
The Immunohistochemistry (IHC) market is segmented by offering into antibodies, reagents, equipment, kits, and software. Antibodies hold the dominant share in this market due to their critical role in specifically binding to target antigens in tissue samples, which is essential for accurate biomarker identification. The high demand for diverse and highly specific antibodies, coupled with ongoing innovations in antibody development, drives significant revenue growth. Reagents support various stages of staining and visualization, while equipment—including microscopes, slide scanners, and automated staining systems—facilitates the execution and analysis of tests. Kits offer ready-to-use combinations of antibodies and reagents that simplify laboratory workflows, and software solutions enhance accuracy and efficiency through advanced image analysis and data management. According to the U.S. National Cancer Institute, government funding for biomarker research and diagnostic technologies has increased by over 15% in the last five years, underscoring the growing emphasis on antibody-driven diagnostics and research tools that fuel the IHC market.
By application, the IHC market is divided into diagnostic, research, and forensic applications. Diagnostic applications dominate the market, driven by the increasing need for precise and early disease detection, particularly in oncology. IHC plays a pivotal role in identifying and classifying cancers by detecting specific biomarkers in patient tissue samples, which supports personalized treatment planning and improved patient outcomes. Research applications focus on disease mechanisms, drug development, and biomarker discovery in academic and laboratory settings, while forensic applications utilize IHC for tissue identification in criminal investigations. The rising global prevalence of chronic diseases and the growing adoption of personalized medicine have intensified the demand for IHC diagnostics. Government initiatives, such as the U.S. Precision Medicine Initiative, which allocated billions to enhance diagnostic tools and cancer research, highlight the critical support behind expanding IHC applications in clinical settings, reinforcing diagnostics as the largest and fastest-growing segment in this market.
Immunohistochemistry Market- Geographical Insights
Geographically, the Immunohistochemistry (IHC) market is spread across North America, Asia Pacific, Latin America, Europe, the Middle East, and Africa, with each region segmented by key contributing countries.
North America holds a dominant position in the IHC market, driven by its advanced healthcare infrastructure, high adoption of innovative diagnostic technologies, and substantial investments in research. The presence of leading pharmaceutical and biotechnology companies, alongside strong government funding for cancer and chronic disease research, fuels market expansion. Notably, the U.S. government, through agencies like the National Cancer Institute (NCI), allocates billions annually for cancer diagnostics and personalized medicine initiatives, significantly supporting IHC market growth. Additionally, growing awareness of personalized medicine and the importance of early disease diagnosis has accelerated the adoption of IHC techniques. The United States leads the region with robust demand for precise diagnostic tools, well-established reimbursement frameworks, and a large patient population, making North America a major contributor to global market revenue.
Europe also commands a significant share of the IHC market, supported by well-developed healthcare systems and a rising prevalence of cancer and other chronic diseases. Countries such as Germany, the UK, and France are at the forefront of adopting advanced IHC technologies, bolstered by government initiatives and strong research funding. The European Union, through programs like Horizon Europe, dedicates extensive funding towards cancer research and precision diagnostics, further driving demand for IHC technologies. The increasing emphasis on precision medicine, along with expanding biopharmaceutical research activities, fuels market growth. Europe benefits from a comprehensive network of diagnostic laboratories and academic institutions, fostering the widespread use of IHC in both clinical diagnostics and research, solidifying its status as a leading regional market worldwide.
Immunohistochemistry Market- Competitive Landscape:
The Immunohistochemistry (IHC) market is dominated by established industry leaders such as Thermo Fisher Scientific, Danaher Corporation, F. Hoffmann-La Roche Ltd, and Bio-Rad Laboratories. These companies prioritize innovation, product quality, and regulatory compliance, offering extensive portfolios that include antibodies, reagents, kits, and instruments for both clinical diagnostics and research applications. Significant investments in research and development enable them to improve product sensitivity and specificity, meeting the increasing demand for personalized medicine and precise disease detection. Alongside these major players, emerging companies contribute by developing novel technologies, intensifying competition that drives continuous advancements in IHC methods and broadens their adoption across healthcare and research sectors globally.
Recent Developments:
- In March 2025, Thermo Fisher Scientific Inc. introduced a new automated IHC staining platform aimed at enhancing throughput and reproducibility in clinical laboratories.
- In December 2024, Danaher Corporation acquired a leading digital pathology software company to strengthen its IHC image analysis capabilities and integrate AI-powered diagnostic solutions.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL IMMUNOHISTOCHEMISTRY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- F. Hoffmann-La Roche Ltd
- Danaher Corporation
- Agilent Technologies, Inc
- Thermo Fisher Scientific Inc.
- Merck Kgaa
- Bio-Rad Laboratories, Inc
- Bio-Techne
- Becton, Dickinson And Company
- Takara Bio Inc.
- Enzo Biochem Inc.
- Sino Biological, Inc.
- Sakura Finetek Japan Co., Ltd.
- Cell Signaling Technology, Inc.
- Bio Sb
- Origene Technologies, Inc
- Eaglebio
- Biocare Medical, Llc
- Elabscience Bionovation Inc.
- Biogenex
- Diagnostic Biosystems Inc.
- Histo-Line Laboratories
- Rockland Immunochemicals, Inc.
- Candor Bioscience Gmbh
- Genemed Biotechnologies, Inc.
- Others
GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY OFFERING - MARKET ANALYSIS, 2019 - 2032
- Antibodies
- Primary Antibodies
- Secondary Antibodies
- Monoclonal Antibodies
- Polyclonal Antibodies
- Reagents
- Histological Stains
- Blocking Sera And Reagents
- Chromogenic Substrates
- Fixation Reagents
- Diluents
- Organic Solvents
- Proteolytic Enzymes
- Other Reagents
- Equipment
- Slide-Staining Systems
- Tissue Processing Systems
- Slide Scanners
- Other Equipment
- Kits
- Human Immunohistochemistry Kits
- Animal Immunohistochemistry Kits
- Software
GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY APPLICATION - MARKET ANALYSIS, 2019 - 2032
- Diagnostic Applications
- Cancer
- Infectious Diseases
- Nephrological Diseases
- Autoimmune Diseases
- Neurological Diseases
- Other Diseases
- Research Applications
- Drug Development And Testing
- Other Research Applications
- Forensic Applications
GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY END USER - MARKET ANALYSIS, 2019 - 2032
- Hospitals And Diagnostic Laboratories
- Academic & Research Institutes And Contract Research Organizations
- Other End Users
GLOBAL IMMUNOHISTOCHEMISTRY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Immunohistochemistry Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Immunohistochemistry Market Snippet by Offerings
2.1.2. Immunohistochemistry Market Snippet by Application
2.1.3. Immunohistochemistry Market Snippet by End User
2.1.4. Immunohistochemistry Market Snippet by Country
2.1.5. Immunohistochemistry Market Snippet by Region
2.2. Competitive Insights
3. Immunohistochemistry Key Market Trends
3.1. Immunohistochemistry Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Immunohistochemistry Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Immunohistochemistry Market Opportunities
3.4. Immunohistochemistry Market Future Trends
4. Immunohistochemistry Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Immunohistochemistry Market: COVID-19 Impact Analysis
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. Immunohistochemistry Market Landscape
6.1. Immunohistochemistry Market Share Analysis, 2023
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Immunohistochemistry Market – By Offerings
7.1. Overview
7.1.1. Segment Share Analysis, By Offerings, 2023 & 2032 (%)
7.1.2. Antibodies
7.1.2.1. Primary Antibodies
7.1.2.2. Secondary Antibodies
7.1.2.3. Monoclonal Antibodies
7.1.2.4. Polyclonal Antibodies
7.1.3. Reagents
7.1.3.1. Histological Stains
7.1.3.2. Blocking Sera And Reagents
7.1.3.3. Chromogenic Substrates
7.1.3.4. Fixation Reagents
7.1.3.5. Diluents
7.1.3.6. Organic Solvents
7.1.3.7. Proteolytic Enzymes
7.1.3.8. Other Reagents
7.1.4. Equipment
7.1.4.1. Slide-Staining Systems
7.1.4.2. Tissue Processing Systems
7.1.4.3. Slide Scanners
7.1.4.4. Other Equipment
7.1.5. Kits
7.1.5.1. Human Immunohistochemistry Kits
7.1.5.2. Animal Immunohistochemistry Kits
7.1.6. Software
8. Immunohistochemistry Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2023 & 2032 (%)
8.1.2. Diagnostic Applications
8.1.2.1. Cancer
8.1.2.2. Infectious Diseases
8.1.2.3. Nephrological Diseases
8.1.2.4. Autoimmune Diseases
8.1.2.5. Neurological Diseases
8.1.2.6. Other Diseases
8.1.3. Research Applications
8.1.3.1. Drug Development and Testing
8.1.3.2. Other Research Applications
8.1.4. Forensic Applications
9. Immunohistochemistry Market – By End User
9.1. Overview
9.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
9.1.2. Hospitals And Diagnostic Laboratories
9.1.3. Academic & Research Institutes and Contract Research Organizations
9.1.4. Other End Users
10. Immunohistochemistry Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Immunohistochemistry Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Immunohistochemistry Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.8. France
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. France Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
10.3.8.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.8.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.9. Italy
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. Italy Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
10.3.9.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.9.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.10. Spain
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. United Kingdom Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
10.3.10.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.10.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.11. United Kingdom
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.3. United Kingdom Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
10.3.11.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.11.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.12. Russia
10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.2. Russia Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
10.3.12.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.12.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.13. Netherlands
10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.2. Netherlands Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
10.3.13.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.13.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.14. Sweden
10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.2. Sweden Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
10.3.14.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.14.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.15. Poland
10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.2. Poland Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.3.16. Rest of Europe
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.16.3. Rest of the Europe Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Immunohistochemistry Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.9. South Korea
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. South Korea Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
10.4.9.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.9.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.10. Japan
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. Japan Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
10.4.10.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.10.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.12. Thailand
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Thailand Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.13. Indonesia
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Indonesia Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Immunohistochemistry Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Immunohistochemistry Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Offerings, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Immunohistochemistry Industry
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. F. Hoffmann-La Roche Ltd
11.2.2. Danaher Corporation
11.2.3. Agilent Technologies, Inc
11.2.4. Thermo Fisher Scientific Inc.
11.2.5. Merck Kgaa
11.2.6. Bio-Rad Laboratories, Inc
11.2.7. Bio-Techne
11.2.8. Becton, Dickinson And Company
11.2.9. Takara Bio Inc.
11.2.10. Enzo Biochem Inc.
11.2.11. Sino Biological, Inc.
11.2.12. Sakura Finetek Japan Co., Ltd.
11.2.13. Cell Signaling Technology, Inc.
11.2.14. Bio Sb
11.2.15. Origene Technologies, Inc
11.2.16. Eaglebio
11.2.17. Biocare Medical, Llc
11.2.18. Elabscience Bionovation Inc.
11.2.19. Biogenex
11.2.20. Diagnostic Biosystems Inc.
11.2.21. Histo-Line Laboratories
11.2.22. Rockland Immunochemicals, Inc.
11.2.23. Candor Bioscience Gmbh
11.2.24. Genemed Biotechnologies, Inc.
11.2.25. Others
12. 360 Degree Analyst View
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
